ASSESSMENT OF LDH/ADA RATIO IN PATIENTS WITH AND WITHOUT TUBERCULAR PLEURAL EFFUSION
DOI:
https://doi.org/10.53555/y3s2fk44Keywords:
Tubercular pleural effusion, LDH/ADA ratio, adenosine deaminase, lactate dehydrogenase, pleural fluid diagnostics.Abstract
Background: Tubercular pleural effusion (TPE) is a common manifestation of extrapulmonary tuberculosis, especially in high-burden countries. The diagnostic evaluation typically includes pleural fluid adenosine deaminase (ADA) and lactate dehydrogenase (LDH) levels. Recent studies suggest that the LDH/ADA ratio may enhance diagnostic accuracy and help differentiate TPE from other etiologies.
Aim: To assess the LDH/ADA ratio in patients with confirmed tubercular pleural effusion and evaluate its diagnostic utility.
Methods: This cross-sectional study included 100 patients with exudative pleural effusion, of which 70 had confirmed TPE based on microbiological, histopathological, or clinical criteria, and 30 had non-tubercular exudative effusion. Pleural fluid ADA, LDH, and LDH/ADA ratio were measured. Statistical analysis included ROC curve analysis, sensitivity, specificity, and predictive values.
Results: Mean ADA levels in TPE patients were significantly higher than in non-TPE cases (p<0.001). LDH levels were elevated in both groups, but the LDH/ADA ratio was significantly lower in TPE patients (mean 12.4 ± 4.1) compared to non-TPE patients (mean 28.6 ± 5.9, p<0.001). ROC analysis showed an LDH/ADA ratio cut-off of ≤16.0 had a sensitivity of 91.4% and specificity of 88.3% for diagnosing TPE.
Conclusion: The LDH/ADA ratio is a simple, cost-effective, and valuable adjunctive tool in differentiating tubercular pleural effusion from other exudative pleural effusions.
References
1. WHO Global Tuberculosis Report 2023.
2. Light RW. Update on tuberculous pleural effusion. Respirology. 2010;15(3):451-8.
3. Vorster MJ, et al. The immunopathogenesis of tuberculous pleural effusion. Tuberculosis. 2015;95(6):701-708.
4. Burgess LJ, et al. Use of ADA in the diagnosis of tuberculous pleuritis. Chest. 1995;107(2):295-299.
5. Sharma SK, et al. ADA in the diagnosis of TPE in India. Int J Tuberc Lung Dis. 2001;5(10):978-983.
6. Valdés L, et al. ADA in pleural fluids. Eur Respir J. 1993;6:955-958.
7. Porcel JM, et al. ADA in non-tuberculous effusions. Chest. 2003;124:199-204.
8. Light RW, et al. Pleural effusions: diagnostic approach. N Engl J Med. 2002;346:1971- 1977.
9. Heffner JE, et al. Diagnostic utility of LDH in pleural fluid. Chest. 1997;111:970-980.
10. Burgess LJ, et al. LDH/ADA ratio in pleural effusions. Chest. 1995;108(2):414-419.
11. Diacon AH, et al. Combination biomarkers in TPE diagnosis. Eur Respir J. 2003;21:220- 224.
12. Aggarwal AN, et al. Novel markers in TPE. Lung India. 2005;22(3):131-136.
13. Kaya S, et al. LDH/ADA ratio in differential diagnosis of pleural effusions. Clin Biochem. 2013;46(7-8):649-653.
14. Liang QL, et al. Meta-analysis of ADA and LDH/ADA ratio in TPE diagnosis. Respir Med. 2008;102(3):377-381.
15. Wu YB, et al. Role of LDH/ADA ratio in differentiating malignant and tuberculous effusions. J Thorac Dis. 2014;6(6):845-851.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Population Therapeutics and Clinical Pharmacology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.